115 related articles for article (PubMed ID: 30809967)
21. Effect of coadministration of metformin with mirogabalin: Results from a phase 1, randomized, open-label, drug-drug interaction study
.
Dow J; Currie A; He L; Zaidi F; Zahir H
Int J Clin Pharmacol Ther; 2018 Oct; 56(10):451-458. PubMed ID: 30049303
[TBL] [Abstract][Full Text] [Related]
22. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
Murphy J; Wang SS; Stieltjes H; Wajs E; Devineni D
Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets.
Ghim JL; Phuong NTT; Kim MJ; Kim EJ; Song GS; Ahn S; Shin JG; Kim EY
Drug Des Devel Ther; 2019; 13():1623-1632. PubMed ID: 31190741
[No Abstract] [Full Text] [Related]
24. The steady-state pharmacokinetics and bioequivalence of carprofen administered orally and subcutaneously in dogs.
Clark TP; Chieffo C; Huhn JC; Nimz EL; Wang C; Boy MG
J Vet Pharmacol Ther; 2003 Jun; 26(3):187-92. PubMed ID: 12755902
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjects.
Kim B; Huh KY; Hwang JG; Nah J; Huh W; Cho JM; Jang IJ; Yu KS; Kim Y; Lee S
Br J Clin Pharmacol; 2023 Apr; 89(4):1462-1470. PubMed ID: 36422809
[TBL] [Abstract][Full Text] [Related]
26. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
27. Lack of clinically relevant drug-drug interaction between empagliflozin, a sodium glucose cotransporter 2 inhibitor, and verapamil, ramipril, or digoxin in healthy volunteers.
Macha S; Sennewald R; Rose P; Schoene K; Pinnetti S; Woerle HJ; Broedl UC
Clin Ther; 2013 Mar; 35(3):226-35. PubMed ID: 23497760
[TBL] [Abstract][Full Text] [Related]
28. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetic comparison using two tablets of an evogliptin/metformin XR 2.5/500 mg fixed dose combination vs. 1 tablet each of evogliptin 5 mg and metformin XR 1,000 mg
.
Yoon S; Rhee SJ; Park SI; Yoon SH; Cho JY; Jang IJ; Lee S; Yu KS
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):533-539. PubMed ID: 28406090
[TBL] [Abstract][Full Text] [Related]
30. Effects of food intake on the pharmacokinetic properties of mirabegron oral controlled-absorption system: a single-dose, randomized, crossover study in healthy adults.
Lee J; Zhang W; Moy S; Kowalski D; Kerbusch V; van Gelderen M; Sawamoto T; Grunenberg N; Keirns J
Clin Ther; 2013 Mar; 35(3):333-41. PubMed ID: 23497763
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of neratinib during coadministration with lansoprazole in healthy subjects.
Keyvanjah K; DiPrimeo D; Li A; Obaidi M; Swearingen D; Wong A
Br J Clin Pharmacol; 2017 Mar; 83(3):554-561. PubMed ID: 27628584
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the potential for pharmacokinetic and pharmacodynamic interactions between dutogliptin, a novel DPP4 inhibitor, and metformin, in type 2 diabetic patients.
Li J; Klemm K; O'Farrell AM; Guler HP; Cherrington JM; Schwartz S; Boyea T
Curr Med Res Opin; 2010 Aug; 26(8):2003-10. PubMed ID: 20583949
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects.
Graefe-Mody EU; Padula S; Ring A; Withopf B; Dugi KA
Curr Med Res Opin; 2009 Aug; 25(8):1963-72. PubMed ID: 19552619
[TBL] [Abstract][Full Text] [Related]
34. Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males.
Sasaki T; Seino Y; Fukatsu A; Ubukata M; Sakai S; Samukawa Y
Adv Ther; 2015 May; 32(5):404-17. PubMed ID: 25975816
[TBL] [Abstract][Full Text] [Related]
35. Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
Tippabhotla SK; Betha MR; Gadiko C; Battula R; Nakkawar M; Cheerla R; Khan SM; Yergude S; Thota S; Vobalaboina V
Drug Res (Stuttg); 2013 May; 63(5):250-7. PubMed ID: 23526241
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of a Lobeglitazone/Metformin Fixed-Dose Combination Tablet (CKD-395 0.5/1000 mg) Versus Concomitant Administration of Single Agents and the Effect of Food on the Metabolism of CKD-395 in Healthy Male Subjects.
Kim SY; Jeon JY; Park SJ; Kim MG
Clin Pharmacol Drug Dev; 2019 Jul; 8(5):576-584. PubMed ID: 30329224
[TBL] [Abstract][Full Text] [Related]
37. Investigation of Potential Pharmacokinetic Interactions Between Teneligliptin and Metformin in Steady-state Conditions in Healthy Adults.
Nakamaru Y; Hayashi Y; Davies M; Jürgen Heuer H; Hisanaga N; Akimoto K
Clin Ther; 2015 Sep; 37(9):2007-18. PubMed ID: 26212570
[TBL] [Abstract][Full Text] [Related]
38. Bioequivalence and pharmacokinetic evaluation of two tablet formulations of carvedilol 25-mg: a single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers.
Liu Y; Lu C; Chen Q; Wang W; Liu GY; Lu XP; Zhang MQ; Yu C; Jia JY
Drug Res (Stuttg); 2013 Feb; 63(2):74-8. PubMed ID: 23447077
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO® (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers.
Choi Y; Han H; Shin D; Lim KS; Yu KS
Drug Des Devel Ther; 2015; 9():4127-35. PubMed ID: 26257511
[TBL] [Abstract][Full Text] [Related]
40. Bioequivalence study of cyclizine hydrochloride 50 mg tablets in healthy volunteers: a randomized, open-label, single-dose study.
Abhyankar D; Shedage A; Gole M; Raut P
Ther Deliv; 2016 Aug; 7(8):545-51. PubMed ID: 27444494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]